Larvol Delta - Carisma-Unveils-Promising-PreClinical-Data-on-AntiGPC3-In-Vivo-CARM-Therapy-for-Hepatocellular-Carcinoma

In-Vivo mRNA CAR-M targeting GPC-3 - Moderna

https://www.prnewswire.com/news-releases/carisma-unveils-promising-pre-clinical-data-on-anti-gpc3-in-vivo-car-m-therapy-for-hepatocellular-carcinoma-302299179.html

Nov 8, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next